"Darnița" has entered six new markets in 2024.

In 2024, the pharmaceutical company "Darnitsa" registered 10 new medicinal products abroad and entered the markets of six new countries: the EU, Bosnia and Herzegovina, Israel, New Zealand, and Malaysia.

These medications are used to treat heart and kidney failure, liver diseases, arterial hypertension, as well as to combat infections of the oral cavity and throat.

This was reported by the company.

Also in 2024, "Darnitsa" launched 13 new medicinal products in Ukraine. Among them are medications for the treatment of infections, pain, inflammation, and throat diseases.

By 2029, the company plans to release 62 new brands, most of which will be produced in-house.

Background. It is worth noting that "Darnitsa" made it to the top 30 most digitalized companies in Ukraine according to Forbes Ukraine magazine.